...
首页> 外文期刊>Diseases of the esophagus: official journal of the International Society for Diseases of the Esophagus >Longitudinal outcomes of radiofrequency ablation versus surveillance endoscopy for Barrett's esophagus with low-grade dysplasia
【24h】

Longitudinal outcomes of radiofrequency ablation versus surveillance endoscopy for Barrett's esophagus with low-grade dysplasia

机译:射频消融的纵向结果与Barrett的低级发育不良的食管监测内窥镜检查

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

ABSTRACT: Radiofrequency ablation of Barrett's esophagus with low-grade dysplasia is recommended in recent American College of Gastroenterology guidelines, with endoscopic surveillance considered a reasonable alternative. Few studies have directly compared outcomes of radiofrequency ablation to surveillance and those that have are limited by short duration of follow-up. This study aims to compare the long-term effectiveness of radiofrequency ablation versus endoscopic surveillance in a large, longitudinal cohort of patients with Barrett's esophagus, and low-grade dysplasia. We conducted a retrospective analysis of patients with confirmed low-grade dysplasia at a single academic medical center from 1991 to 2014. Patients progressing to high-grade dysplasia or esophageal adenocarcinoma within one year of index LGD endoscopy were defined as missed dysplasia and excluded. Risk factors for progression were assessed via Cox proportional hazards model. Comparison of progression risk was conducted using a Kaplan-Meier analysis. Subset analyses were conducted to examine the effect of reintroducing early progressors and excluding patients diagnosed prior to the advent of ablative therapy. Of 173 total patients, 79 (45.7%) underwent radiofrequency ablation while 94 (54.3%) were untreated, with median follow up of 90 months. Seven (8.9%) patients progressed to high-grade dysplasia or adenocarcinoma despite ablation, compared with 14 (14.9%) undergoing surveillance (P = 0.44). This effect was preserved when patients diagnosed prior to the introduction of radiofrequency ablation were excluded (8.9% vs 13%, P = 0.68). Reintroduction of patients progressing within the first year of follow-up resulted in a trend toward significance for ablation versus surveillance (11.1% vs 23.8%, P = 0.053). In conclusion, progression to high-grade dysplasia or adenocarcinoma was not significantly reduced in the radiofrequency ablation cohort when compared to surveillance. Despite recent studies suggesting the superiority of radiofrequency ablation in reducing progression, diligent endoscopic surveillance may provide similar long-term outcomes. ? The Author(s) 2017. Published by Oxford University Press on behalf of International Society for Diseases of the Esophagus. All rights reserved.
机译:摘要:在最近美国胃肠学指南中推荐了Barrett食管中的Barrett食管食道的射频消融,内窥镜监测被认为是合理的替代品。少数研究直接比较了射频消融的结果,以监测,并且通过短暂的后续时间受到限制的情况。本研究旨在比较射频消融对Barrett食管患者的大型纵向群体的长期效力与内窥镜监测,以及低级发育不良。我们对1991年至2014年的单一学术医疗中心的患者进行了回顾性分析,从1991年到2014年。在指数LGD内窥镜检查的一年内患者进入高级发育性或食管腺癌的患者被定义为错过的发育不良并且被排除在外。通过COX比例危害模型评估进展的危险因素。使用Kaplan-Meier分析进行了进展风险的比较。进行次集分析以检测重新引入早期进展和排除患者在消融治疗之前诊断的患者的效果。总患者173例,79(45.7%)接受了射频消融,而94(54.3%)未经处理,中位于90个月的中位。七(8.9%)患者仍然融合到高级发育性或腺癌,而蚀刻相比,接受监测(P = 0.44)。当患有引入射频消融之前诊断的患者被排除时保留这种效果(8.9%Vs 13%,P = 0.68)。重新引入在后续行动的第一年内进展导致嗜睡的重要性趋势与监测(11.1%vs 23.8%,p = 0.053)。总之,与监测相比,在射频消融队列中,对高级发育不良或腺癌的进展不会显着降低。尽管最近的研究表明,射频消融在减少进展中的优越性,但勤勉的内窥镜监测可能提供类似的长期结果。还2017年提交人。由牛津大学出版社代表国际食管疾病社会发布。版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号